American Partership For Eosinophilic Disorder
  • shop
  • ytube
  • Twitter
  • Faceboook
  • Pinterest
  • Instagram
  • Mail
  • Join our mailing list
  • Specialist Finder
  • Specialist Sign Up
shop
  • Home
  • About EAD
    • What is an eosinophil-associated disease?
    • Enfermedad eosinofílica
    • EGIDS
      • EoE
      • Acerca de la EoE
      • EC
      • EG
      • EGE
    • Episodic Angioedema with Eosinophilia (Gleich’s Syndrome)
    • Eosinophilic Asthma
    • Eosinophilic Cystitis
    • Eosinophilic Fasciitis
    • Eosinophilic Granulomatosis with Polyangiitis
    • Eosinophilia-Myalgia Syndrome
    • Eosinophilic Pneumonia
    • Hypereosinophilic Syndromes
    • Patient Stories
    • Glossary
  • Resources
    • Articles of Interest
    • Podcast
    • Webinars
    • Navigate Eos Care
    • For Patients
      • For Adults
      • For Kids
      • For Teens
    • For Caregivers
    • For Family and Friends
    • For Healthcare Providers and Researchers
    • External Resources
  • Events
    • EoE National Awareness Campaign 2025
    • Annual Patient Education Conference
    • Eos Support Webinar Series
    • World Eosinophilic Disease Day (May 18)
    • National Eosinophil Awareness Week (May 18-24, 2025)
    • World Eosinophilic Esophagitis (EoE) Day | May 22, 2025
    • Community Partner Events & Fundraisers
  • Research
    • APFED’s HOPE on the Horizon Research Program
    • APFED Funded Research/Grant Recipients
    • Grant Application for Researchers
    • APFED Research Abstract Awards
    • Enroll in Patient Registry
    • Consortium of EGID Researchers (CEGIR)
    • Clinical Trials
    • Published Research
    • Research Surveys, Interviews, and Perspectives
  • Advocacy
    • Current Initiatives and Advocacy History
    • Patient Charter for Eosinophil-Associated Diseases
    • EoE Patient Experience and Opportunities in U.S.
    • Global EoE Policy
    • Medical Foods & Insurance Coverage
    • State Insurance Mandates for Elemental Formula
    • School advocacy
  • Find Support & Treatment
    • Specialist Finder
    • Support Groups
    • Online Community
    • BiologicMeds.org
    • Assistance Programs and Resources
  • Take Action
    • Donate to APFED
    • Ways To Give
    • Subscribe to Free E-news
    • Volunteer
    • Patient Voice: Share Your Story
    • Patient Registries
    • Store
    • Raise Awareness
    • Clinical Trials
    • Research Surveys, Interviews, and Perspectives
    • Corporate Partnerships
  • Media
    • Announcements
    • In The News
    • Press Releases
    • Media Info
  • About APFED
    • Mission and Objectives
    • History
    • Board of Directors
    • Health Sciences Advisory Council
    • Financial and Annual Reports
    • Contact
  • Donate Today

2018-01-29 14:33:48

Adam Rantz Memorial Golf Outing

2018-01-18 12:39:30

Together, We Did It!

Thank you for helping us meet — and beat! — the $150,000 HOPE Challenge! It’s official: Challenge-eligible g ...

Find out More

2017-12-14 12:48:43

Breaking News: EGPA Treatment Approved

GlaxoSmithKline has announced that the FDA has approved Nucala (mepolizumab) as the first targeted treatment for eosinophilic granulomatosis with polyangiitis ( ...

Find out More

2017-12-06 16:10:26

Your Donations at Work

Read how APFED has moved its mission forward this year, ...

Find out More

2017-11-22 11:26:23

Support APFED While You Shop!

Support APFED when you shop on Black Friday and throughout the year. Go to ...

Find out More
  • « Previous 1 … 29 30 31 32 33 … 48 Next »

Follow Us On

YouTube Twitter Facebook Pinterest

Subscribe Newsletter

Get Inspired! Travel ideas from across the world straight to your inbox.

Subscribe Now

Recent Posts

2025-09-24 22:43:44

Research Roundup, September 2025

2025-09-19 09:58:07

College Life with an Eosinophil Associated Disease

2025-08-18 10:14:10

Adam’s Legacy: A Commitment to Eosinophilic Disease Research

Join our mailing list
Join

About APFED

APFED is a 501(c)3 organization dedicated to patients and their families coping with eosinophilic disorders. APFED educates, creates awareness, funds research and advocates.

Tax ID: 76-0700153

 

Partner with APFED

Explore Corporate Partnerships

Contact

Mailing Address:
APFED
American Partnership for Eosinophilic Disorders
2897 N. Druid Hills Rd., Suite 128
Atlanta, GA 30359

Phone: (713) 493-7749
(9 AM – 5 PM ET, Monday – Friday)

Inquiries

General: mail@apfed.org
Media: media@apfed.org | Press Kit
Fundraising, Corporate Donations, Matching Funds: fundraise@apfed.org
Legislative Issues: pac@apfed.org
Website: webmaster@apfed.org

 

Specialist Finder

For assistance in finding a medical professional in your area, please explore our Specialist Finder.

Footer Awards

NORD Member Guidestar Badge

copyright

The information provided on apfed.org is designed to support, not to replace, the relationship that exists between a patient/site visitor and their physician.
Copyright © 2001-2025 American Partnership for Eosinophilic Disorders.

Privacy Policy | Terms of Use